What is Abbott's D&A?

Abbott (ABT) reported D&A of $402M in Q2 2026.

How has Abbott's D&A changed year-over-year?

Abbott's D&A increased by 12.6% year-over-year, from $357M to $402M.

What is the long-term trend for Abbott's D&A?

Over 4 years (2021 to 2025), Abbott's D&A has grown at a -1.0% compound annual growth rate (CAGR), from $1.49B to $1.43B.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Abbott ABT D&A

D&A at other companies

Becton, Dickinson and CompanyBDX

$563M-0.7%

Johnson & JohnsonJNJ

$1.96B+0.8%

HaemoneticsHAE

$27.32M-3.2%

ArtivionAORT

$6.34M+16.4%

Merit Medical SystemsMMSI

$30.5M+4.1%

Boston ScientificBSX

$351M+8.0%

Segments

By segment

See full

Diagnostic Products$165M+22.2%

Medical Devices$106M+12.8%

Nutritional Products$51M+15.9%

Established Pharmaceuticals$25M0.0%

Other financials

Income statement

See full

Revenue$12.6B+13.0%

Gross profit$7.3B+15.6%

Operating income$1.7B-17.5%

Net income$928.0M-47.8%

EPS (diluted)$0.53-47.5%

Balance sheet

See full

Cash & equivalents$5.1B-26.6%

Total debt$32.6B+143%

Total equity$51.1B+1.1%

Total assets$109.22B+30.0%

Cash flow

See full

Operating cash flow$2.5B+21.5%

CapEx$497.0M-1.0%

Free cash flow$2.0B+28.9%

Valuation

See full

Market cap$182.75B-16.8%

Enterprise value$210.25B-7.0%

P/E33.7×+18.0×

P/S3.9×-1.2×

Profitability

See full

Gross margin56.6%+0.6pp

Operating margin15.8%-1.7pp

Net margin11.6%-20.8pp

FCF margin16.8%+1.1pp

Returns & leverage

See full

Return on equity10.7%-20.4pp

Debt / equity0.6×+0.4×

Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Abbott’s 10-Q, filed July 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Abbott's D&A?: Abbott (ABT) reported D&A of $402M in Q2 2026.
How has Abbott's D&A changed year-over-year?: Abbott's D&A increased by 12.6% year-over-year, from $357M to $402M.
What is the long-term trend for Abbott's D&A?: Over 4 years (2021 to 2025), Abbott's D&A has grown at a -1.0% compound annual growth rate (CAGR), from $1.49B to $1.43B.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.